{"id":"10a45c58-71d9-4c90-bec4-c37226e37735","slug":"usitc-337-ta-1276-apple-watch-spo2","filingNumber":"337-TA-1276","filingType":"itc_exclusion_order","jurisdiction":"us_itc","applicantCompanyId":"9d5d53e7-65ec-4e6c-80e0-86c94bff0f48","filingDate":"2021-08-13T12:00:00.000Z","decisionDate":"2023-10-26T12:00:00.000Z","status":"active","clearanceScope":"US ITC Section 337 exclusion order (Masimo pulse-oximetry patents) led Apple to disable / redesign the blood-oxygen (SpO2) feature on US Apple Watch units from January 2024. SpO2 is not marketed as an FDA-cleared medical claim.","sources":[{"url":"https://www.usitc.gov","title":"USITC Inv. No. 337-TA-1276 (Masimo v. Apple, pulse oximetry)","sourceName":"US International Trade Commission"}],"verificationPosture":"verified","capFlagNotes":"Honest-absence + enforcement: SpO2 is NOT an FDA-cleared medical function; the ITC order is a patent-import matter, distinct from any FDA clearance.","relatedIncidentId":null,"reviewStatus":"reviewed","deprecatedAt":null,"deprecationReason":null,"createdAt":"2026-06-04T23:08:19.577Z","updatedAt":"2026-06-05T15:35:56.257Z","applicantCompany":{"id":"9d5d53e7-65ec-4e6c-80e0-86c94bff0f48","slug":"apple","name":"Apple"},"modelLinks":[{"id":"1f28e887-8f40-4464-9f55-65c6042fed2c","modelId":"7af0d52f-fb71-4b04-88e9-413ec552cb52","regulatoryFilingId":"10a45c58-71d9-4c90-bec4-c37226e37735","createdAt":"2026-06-04T23:08:19.731Z","model":{"slug":"apple-watch","modelName":"Apple Watch"}}]}